Select Medical Unit Concentra Files for U.S. IPO
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,800 Today
Ensign Group (NASDAQ:ENSG) has outperformed the market over the past 15 years by 9.01% on an annualized basis producing an average annual return of 21.55%. Currently, Ensign Group has a market capital
4 Constructive Medical Devices Stocks - BTIG
AMD To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Susquehanna
Stocks With the Highest and Lowest Liquidity - Goldman Sachs
HC Wainwright & Co. Reiterates Neutral on Alkermes, Maintains $35 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Alkermes (NASDAQ:ALKS) with a Neutral and maintains $35 price target.
Ensign Group Acquires 32-Bed Skilled Nursing Facility In Gilbert, Arizona; Also Buys 58-Bed Skilled Nursing Facility In Aurora, Colorado; No Terms Disclosed
The real estate was acquired by a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign's captive real estate company, and the acquisition was effective as of June 1, 2024.In a separate transact
Alkermes Unveils Phase 1b Data for Narcolepsy Treatment at SLEEP 2024
Alkermes plc (NASDAQ:ALKS) today announced new data from the full narcolepsy type 1 (NT1) cohort of a phase 1b, proof-of-concept study evaluating ALKS 2680, the company's novel, investigational, oral
Redburn Atlantic Initiates Coverage On Tandem Diabetes Care With Buy Rating, Announces Price Target of $60
Redburn Atlantic analyst Issie Kirby initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Buy rating and announces Price Target of $60.
Alkermes to Present Promising Narcolepsy Treatment Data at Annual Sleep Conference
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024PRNewswire– Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibran
6 Analysts Assess Alkermes: What You Need To Know
Alkermes (NASDAQ:ALKS) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The following table encapsulates their recent ratings
Alkermes Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/23/2024 98.27% Cantor Fitzgerald $43 → $48 Maintains Overweight 05/02/2024 44.57% HC Wainwright & Co. →
Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'
On CNBC's "Mad Money Lightning Round," Jim Cramer said Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a "terrific spec" and he recommended buying the same.On May 9, Recursion Pharmaceuticals reporte
Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)
Glaukos (NYSE:GKOS) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a concise overview of recent r
Citi Upgrades Edwards, Tandem; Cuts Nevro, Establishment Labs
Glaukos Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/22/2024 20% Citigroup $120 → $130 Maintains Buy 05/06/2024 15.39% Jefferies $84 → $125 Upgrades Hold →
Lake Street Maintains Buy on Tandem Diabetes Care, Raises Price Target to $75
Lake Street analyst Brooks O'Neil maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Buy and raises the price target from $60 to $75.
Tandem Diabetes Care Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/22/2024 7.76% Stifel $45 → $55 Maintains Buy 05/06/2024 7.76% Barclays $39 → $55 Maintains Overweight 0
Meme Stocks GameStop, AMC Fade In Interest After Roaring Kitty Exit: Here's What WallStreetBets Is Eyeing Next
A rally in meme stocks like GameStop Corporation (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) appears to be short-lived after the return and recent farewell from Roaring Kitty on social media.
XPeng Posts Strong Results, Joins Larimar Therapeutics, Transcat And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mostly higher, with the Dow Jones index gaining around 50 points on Tuesday.Shares of XPeng Inc. (NYSE:XPEV) rose sharply during Tuesday's session after the company reported better-th